Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Pegvaliase

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioMarin's Data for Palynziq in Adolescents with Phenylketonuria
    BioMarin's Data for Palynziq in Adolescents with Phenylketonuria

    02 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biomarin-announces-positive-pivotal-data-for-palynziq-pegvaliase-pqpz-in-adolescents-with-phenylketonuria-302417762.html

    PR NEWSWIRE
    02 Apr 2025
    Share Share
    BioMarin's Biologic Palynziq (pegvaliase) Receives Approval in the U.S.
    BioMarin's Biologic Palynziq (pegvaliase) Receives Approval in the U.S.

    09 Dec 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079

    FDA
    09 Dec 2023
    Share Share
    Biomarin Pharm`s Biological Palynziq (pegvaliase-pqpz) Receives Approval In US
    Biomarin Pharm`s Biological Palynziq (pegvaliase-pqpz) Receives Approval In US

    25 Nov 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079

    FDA
    25 Nov 2020
    Share Share
    Biomarin Pharm's Biological Pegvaliase-Pqpz Receives Approval In US
    Biomarin Pharm's Biological Pegvaliase-Pqpz Receives Approval In US

    08 Oct 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079

    FDA
    08 Oct 2020
    Share Share
    BioMarin, Pioneer in Rare Disease (PKU), Receives FDA Approval Label Expansion
    BioMarin, Pioneer in Rare Disease (PKU), Receives FDA Approval Label Expansion

    07 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/biomarin-pioneer-in-rare-disease-treatments-for-phenylketonuria-pku-receives-fda-approval-of-label-expansion-to-allow-maximum-dose-of-60-mg-for-palynziq-pegvaliase-pqpz-injection-for-treatment-of-adults-with-pku-301147358.html

    PRNEWSWIRE
    07 Oct 2020
    Share Share
    EU nod for BioMarin’s second PKU therapy Palynziq
    EU nod for BioMarin’s second PKU therapy Palynziq

    07 May 2019

    // Andrew McConaghie PMLIVE

    http://www.pmlive.com/pharma_news/eu_nod_for_biomarins_second_pku_therapy_palynziq_1286947

    Andrew McConaghie PMLIVE
    07 May 2019
    Share Share